Variations in Infant CYP2B6 Genotype Associated with the Need for Pharmacological Treatment for Neonatal Abstinence Syndrome in Infants of Methadone-Maintained Opioid-Dependent Mothers.

Mactier, H., McLaughlin, P., Gillis, C. and Osselton, D. M., 2017. Variations in Infant CYP2B6 Genotype Associated with the Need for Pharmacological Treatment for Neonatal Abstinence Syndrome in Infants of Methadone-Maintained Opioid-Dependent Mothers. American Journal of Perinatology, 34 (9), 918 - 921.

Full text available as:

[img] PDF
AJP_160470.pdf - Accepted Version
Restricted to Repository staff only until 20 March 2018.
Available under License Creative Commons Attribution Non-commercial No Derivatives.

151kB

Official URL: https://doi.org/ 10.1055/s-0037-1600917

DOI: 10.1055/s-0037-1600917

Abstract

Background Neonatal abstinence syndrome (NAS) in infants of methadone-maintained opioid-dependent (MMOD) mothers cannot be predicted in individual cases. We investigated whether variation in infant genotype is associated with severity of NAS. Methods This is a pilot observational cohort study of 21 MMOD mothers and their newborns. Infant buccal swabs were obtained soon after delivery, together with a maternal blood sample for the determination of maternal plasma methadone concentration. Genomic variation in five opioid-related genes (ABCB1, COMT, CYP2B6, CYP2D6, and OPRM1) was ascertained from infant buccal swabs and related to need for pharmacological treatment of NAS. Results Out of 21 infants, 11 (52%) required treatment for NAS. Mothers of treated infants tended to have been prescribed higher doses of methadone, but plasma methadone concentrations did not differ between mothers of treated or untreated babies. Treated and untreated babies did not differ in terms of method of feeding. Treated infants were more likely to carry the normal (homozygous) allele at 516 and 785 regions of CYP2B6 gene (p = 0.015 and 0.023, respectively). There were no differences in any other genes between infants who did or did not require treatment for NAS. Conclusion Genomic variation in CYP2B6 may explain, at least in part, severity of NAS.

Item Type:Article
ISSN:0735-1631
Uncontrolled Keywords:neonatal abstinence syndrome; newborn; methadone; genotype
Group:Faculty of Science & Technology
ID Code:29593
Deposited By: Unnamed user with email symplectic@symplectic
Deposited On:16 Aug 2017 08:40
Last Modified:16 Aug 2017 08:40

Downloads

Downloads per month over past year

More statistics for this item...
Repository Staff Only -